Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Therapeutics (MT) and Population Studies Research Program (PS Research Program).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

Karmanos, WSU Faculty Members Selected by Michigan Cancer Consortium to Support Statewide Cancer Control Efforts

The Michigan Cancer Consortium (MCC) has selected two Barbara Ann Karmanos Cancer Institute researchers and Wayne State University School of Medic...

Read More

Abstracts Now Accepted for 3rd Annual Science of Community Outreach and Engagement Conference, Co-Hosted by Karmanos, WSU

Abstracts are now being accepted for the Science of Community Outreach and Engagement Conference (SoCOE), which will be held May 6-8 at the Cambri...

Read More

Karmanos Cancer Institute Receives the 2026 Women’s Choice Award® as One of America’s Best Hospitals for Cancer Care

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 20...

Read More
News

WSGW | Risks of Pancreatic Cancer

Listen Now

WWJ | Karmanos Psychologist on Emotional Impact of Breast Cancer Diagnosis

Listen Now

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now